RECRUITING

Neuromodulation of Memory in Aging

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The proposed research will use closed-loop transcranial magnetic stimulation (TMS) based on individualized brain networks to establish parameters that can reliably control brain states. This will be tested in healthy aging and mild cognitive impairment (MCI) cohorts. The investigators will study network activation and neural oscillatory mechanisms underlying the network that regulates working memory and then target this network using closed-loop TMS to the Prefrontal Cortex. Investigators will measure the impact of TMS on working memory performance and task-based neural activity. The project will use brain stimulation and network modeling techniques to enhance working memory in healthy older adults and MCI and will demonstrate the value of closed-loop, network-guided TMS for future clinical applications.

Official Title

Adaptive Neuromodulation of Working Memory Networks in Aging and Dementia

Quick Facts

Study Start:2024-03-28
Study Completion:2027-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05460468

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * English Speaking
  2. * Willing to provide consent
  1. * History of any Axis I DSM-V disorder, excluding major depressive disorder or generalized anxiety disorders
  2. * Current history of substance abuse or dependence (excluding nicotine)
  3. * Intracranial implants (e.g. aneurysms clips, shunts, stimulators, cochlear implants, or electrodes), cardiac pacemakers, or vagus Nerve stimulation device
  4. * Increased risk of seizure for any reason, including prior diagnosis of epilepsy, seizure disorder, increased intracranial pressure, or history of significant head trauma with loss of consciousness for ≥ 5 minutes.
  5. * Neurological disorder including, but not limited to: space occupying brain lesion; any history of seizures, history of cerebrovascular accident; fainting, cerebral aneurysm, Dementia, Hungtington chorea; Multiple Sclerosis.
  6. * Current use of medications known to lower the seizure threshold and/or affect working memory

Contacts and Locations

Study Contact

Simon W Davis, PhD
CONTACT
9196841243
simon.davis@duke.edu
Emily Finch, BA
CONTACT
9196682299
emily.finch@duke.edu

Principal Investigator

Simon W Davis, PhD
PRINCIPAL_INVESTIGATOR
Duke University

Study Locations (Sites)

Duke University Hospital
Durham, North Carolina, 27710
United States

Collaborators and Investigators

Sponsor: Duke University

  • Simon W Davis, PhD, PRINCIPAL_INVESTIGATOR, Duke University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-28
Study Completion Date2027-06-30

Study Record Updates

Study Start Date2024-03-28
Study Completion Date2027-06-30

Terms related to this study

Keywords Provided by Researchers

  • TMS
  • Transcranial Magnetic Stimulation
  • Memory

Additional Relevant MeSH Terms

  • Mild Cognitive Impairment
  • MCI